Cogent Biosciences's market cap is currently $1.75B. The company's EPS TTM is $-0.595; its P/E ratio is ―; Cogent Biosciences is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.
